[Topical therapy of ulcerative colitis]

Rogler, G; Beglinger, C; Mottet, C; Seibold, F; Gross, V (2011). [Topical therapy of ulcerative colitis]. Praxis - schweizerische Rundschau für Medizin, 100(23), pp. 1413-24. Bern: Huber 10.1024/1661-8157/a000722

Full text not available from this repository.

The availability of new topical preparations for the treatment of left sided ulcerative colitis ulcerosa offers a therapy optimization for many patients. Rectal application of steroids and 5-aminosalicylic acid (5-ASA) is associated with fewer side effects and has a higher therapeutic efficacy in mild to moderate-active left-sided colitis as compared to a systemic therapy. Often it is argued that the patients' compliance is insufficient with a rectal therapy. However, with sufficient information on the proven advantages this is usually not the case. The rectal application of drugs in distal ulcerative colitis is suitable also for the maintenance of remission. Therefore the new therapy guidelines recommend topical therapy more than in former times. Subsequently, these manuscripts focussed specifically on the topical therapy of distal colitis, to elucidate that clear treatment advantages are present in daily practice.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
UniBE Contributor:	Seibold, Frank Werner
ISSN:	1661-8157
Publisher:	Huber
Language:	German
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:22
Last Modified:	05 Dec 2022 14:06
Publisher DOI:	10.1024/1661-8157/a000722
PubMed ID:	22086380
URI:	https://boris.unibe.ch/id/eprint/7745 (FactScience: 213071)